Cite
HARVARD Citation
Lin, T. et al. (2017). CYP2C19 polymorphism has no influence on rabeprazole‐based sequential therapy. Advances in digestive medicine. 4 (4), pp. 134-139. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lin, T. et al. (2017). CYP2C19 polymorphism has no influence on rabeprazole‐based sequential therapy. Advances in digestive medicine. 4 (4), pp. 134-139. [Online].